financetom
Business
financetom
/
Business
/
Virgin Australia executives set to meet investors ahead of re-listing, says source
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Virgin Australia executives set to meet investors ahead of re-listing, says source
Mar 30, 2025 7:54 PM

(Reuters) -Virgin Australia executives will begin meeting with prospective investors on Tuesday ahead of a potential relisting of the Bain Capital-owned airline, according to a person familiar with the matter.

Australia's second-largest airline which competes with larger Qantas in the domestic aviation market, collapsed in 2020 following tough COVID-19 restrictions that damaged the global airline industry. Virgin executives plan to meet prospective investors on Tuesday to pitch the company's surge in profitability, the person added.The person could not be named as they were not authorised to comment to the media. Virgin referred a Reuters request for comment to Bain, which declined to comment. Bain bought out Virgin for about A$3.5 billion ($2.20 billion) after the airline called in external administrators, an Australian equivalent of bankruptcy protection, in the early months of the pandemic when abrupt flight cancellations hurt its ability to service debts.

As the end of most pandemic restrictions prompted a surge of demand for travel in 2022, Bain began exploring a possible Initial Public Offer, but the private equity firm paused preparations for a listing in 2023 due to volatile equity markets, a person familiar with the matter said at the time.

On Tuesday, Virgin Chief Executive Dave Emerson, who started in the job this month, will begin a non-deal roadshow to discuss the company's prospects with fund managers, the person with knowledge of the situation told Reuters.

($1 = 1.5896 Australian dollars)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Reddit Insider Sold Shares Worth $15,844,168, According to a Recent SEC Filing
Reddit Insider Sold Shares Worth $15,844,168, According to a Recent SEC Filing
Mar 19, 2025
03:17 AM EDT, 03/19/2025 (MT Newswires) -- Steve Ladd Huffman, 10% Owner, Director, Chief Executive Officer & President, on March 14, 2025, sold 124,408 shares in Reddit ( RDDT ) for $15,844,168. Following the Form 4 filing with the SEC, Huffman has control over a total of 583,515 Class A common shares of the company, with 583,515 controlled indirectly. SEC...
Workday Insider Sold Shares Worth $21,463,877, According to a Recent SEC Filing
Workday Insider Sold Shares Worth $21,463,877, According to a Recent SEC Filing
Mar 19, 2025
03:19 AM EDT, 03/19/2025 (MT Newswires) -- David A Duffield, 10% Owner, on March 14, 2025, sold 86,672 shares in Workday (WDAY) for $21,463,877. Following the Form 4 filing with the SEC, Duffield has control over a total of 147,997 Class A common shares of the company, with 102,997 shares held directly and 45,000 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1327811/000132781125000064/xslF345X05/wk-form4_1742338846.xml ...
Pfizer sells entire Haleon stake for $3.24 billion
Pfizer sells entire Haleon stake for $3.24 billion
Mar 19, 2025
March 19 (Reuters) - Drugmaker Pfizer has sold its entire stake in Haleon ( HLN ) for about 2.5 billion pounds ($3.24 billion) to institutional investors and the consumer healthcare firm at 385 pence per share, a bookrunner for the deal said on Wednesday. ($1 = 0.7708 pounds) (Reporting by Anandita Mehrotra in Bengaluru; Editing by Mrigank Dhaniwala) ...
Rhythm Pharmaceuticals Insider Sold Shares Worth $3,861,272, According to a Recent SEC Filing
Rhythm Pharmaceuticals Insider Sold Shares Worth $3,861,272, According to a Recent SEC Filing
Mar 19, 2025
03:13 AM EDT, 03/19/2025 (MT Newswires) -- Yann Mazabraud, Executive Vice President, Head of International, on March 14, 2025, sold 75,000 shares in Rhythm Pharmaceuticals ( RYTM ) for $3,861,272. Following the Form 4 filing with the SEC, Mazabraud has control over a total of 40,370 common shares of the company, with 40,370 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1649904/000110465925025236/xslF345X05/tm259548-1_4seq1.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved